ATE209922T1 - Pharmazeutische zusammensetzung von stickstoffmonoxid - Google Patents

Pharmazeutische zusammensetzung von stickstoffmonoxid

Info

Publication number
ATE209922T1
ATE209922T1 AT96934916T AT96934916T ATE209922T1 AT E209922 T1 ATE209922 T1 AT E209922T1 AT 96934916 T AT96934916 T AT 96934916T AT 96934916 T AT96934916 T AT 96934916T AT E209922 T1 ATE209922 T1 AT E209922T1
Authority
AT
Austria
Prior art keywords
pct
nitrogen monoxide
pharmaceutical composition
date
sec
Prior art date
Application number
AT96934916T
Other languages
English (en)
Inventor
Robert Briend
Marie-Helene Renaudin
Original Assignee
Air Liquide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide filed Critical Air Liquide
Application granted granted Critical
Publication of ATE209922T1 publication Critical patent/ATE209922T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96934916T 1995-10-20 1996-10-15 Pharmazeutische zusammensetzung von stickstoffmonoxid ATE209922T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512345 1995-10-20
PCT/FR1996/001610 WO1997015311A1 (fr) 1995-10-20 1996-10-15 Composition a base de monoxyde d'azote en tant que medicament

Publications (1)

Publication Number Publication Date
ATE209922T1 true ATE209922T1 (de) 2001-12-15

Family

ID=9483741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934916T ATE209922T1 (de) 1995-10-20 1996-10-15 Pharmazeutische zusammensetzung von stickstoffmonoxid

Country Status (9)

Country Link
US (2) US6051241A (de)
EP (2) EP0855912B1 (de)
JP (2) JPH11513703A (de)
AT (1) ATE209922T1 (de)
AU (2) AU701760B2 (de)
CA (1) CA2188238A1 (de)
DE (1) DE69617719D1 (de)
ES (1) ES2167608T3 (de)
WO (2) WO1997015311A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6106497A (en) * 1997-01-31 2000-08-22 Medical Instrument Development Laboratories System and method for preventing an air embolism in a surgical procedure
EP0887076A3 (de) * 1997-05-07 1999-03-31 Saturnus A.G. Verhinderung von Gewebeverklebung und ein dafür vorgesehenes endoskopisches System zum Aufblasen einer Körperhöhle
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
FR2775967B1 (fr) * 1998-03-10 2000-06-23 Air Liquide Melange gazeux conditionne supercritique contenant du co2, du no et eventuellement du gaz neutre
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel
US6503740B1 (en) 2000-02-22 2003-01-07 Biomin, Inc. Organically modified mineral materials containing engrafted bacteria for chemical contaminant decomposition
WO2001070289A2 (en) 2000-03-20 2001-09-27 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
CN1668315A (zh) * 2002-06-12 2005-09-14 梅瑟·格里斯海姆有限公司 使用含氙气体进行脑保护
WO2003105872A1 (de) * 2002-06-12 2003-12-24 Messer Griesheim Gmbh Xenonhaltiges spasmolytikum
EP1521598A1 (de) * 2002-07-05 2005-04-13 Air Liquide Deutschland GmbH Xenon enthaltendes adjuvans
DE10336768B4 (de) * 2002-08-10 2010-09-09 Air Liquide Deutschland Gmbh Medikament zur Verbesserung der Sauerstoffutilation
EP1556121B1 (de) 2002-10-28 2016-06-01 Northgate Technologies Incorporated Insufflationssystem mit einem Insufflatorschlauch mit mehrfacher Kapazität
US7654975B2 (en) * 2003-04-24 2010-02-02 Northgate Technologies, Inc. Mixed-gas insufflation system
CA2538456C (en) * 2003-10-07 2013-01-15 Northgate Technologies Inc. System and method for delivering a substance to a body cavity
CA2543680C (en) * 2003-10-31 2012-05-22 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
SE0402221D0 (sv) 2004-09-14 2004-09-14 Aerocrine Ab Treatment of insufficient perfusion
WO2006089028A2 (en) * 2005-02-15 2006-08-24 Lab39, Llc Foaming compositions and methods
CA2933737C (en) * 2006-08-04 2020-12-29 Northgate Technologies Inc. In-dwelling port for access into a body
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
EP2704577A4 (de) * 2011-05-05 2014-10-15 Cedars Sinai Medical Center Bewertung einer koronaren herzkrankheit mit kohlendioxid
US11129911B2 (en) 2011-05-05 2021-09-28 Cedars-Sinai Medical Center Assessment of coronary heart disease with carbon dioxide
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
EP4082552B1 (de) 2013-03-15 2026-05-06 The Board of Regents of the University of Texas System Edelgasreiche flüssigkeiten sowie verfahren zu deren herstellung und verwendung
US9517318B2 (en) 2013-06-28 2016-12-13 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir
US9522248B2 (en) 2013-06-28 2016-12-20 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage
US9492626B2 (en) 2013-06-28 2016-11-15 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Breathing assistance assemblies suitable for long term no therapy
US9522247B2 (en) 2013-06-28 2016-12-20 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Method of treating a patient having pulmonary hypertension by long term NO therapy
US9486600B2 (en) 2013-06-28 2016-11-08 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Nasal cannula assembly with inhalation valves communicating with a deformable reservoir
US9566407B2 (en) 2013-06-28 2017-02-14 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Nasal cannula assembly with flow control passage communicating with a deformable reservoir
WO2015021078A1 (en) 2013-08-05 2015-02-12 Cedars-Sinai Medical Center Methods for reducing ischemia-reperfusion injury
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
GB2579240B (en) 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New medical uses
CN111840583B (zh) * 2020-08-06 2023-03-28 温州医科大学 血管内皮损伤治疗的药物制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
DE122007000103I1 (de) * 1990-12-05 2008-04-03 Gen Hospital Corp Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation

Also Published As

Publication number Publication date
JPH11513703A (ja) 1999-11-24
EP0859620A1 (de) 1998-08-26
DE69617719D1 (de) 2002-01-17
ES2167608T3 (es) 2002-05-16
JPH11513705A (ja) 1999-11-24
AU7305196A (en) 1997-05-15
EP0855912B1 (de) 2001-12-05
AU701760B2 (en) 1999-02-04
WO1997015311A1 (fr) 1997-05-01
CA2188238A1 (fr) 1997-04-21
AU7305896A (en) 1997-05-15
US5670177A (en) 1997-09-23
US6051241A (en) 2000-04-18
WO1997015312A1 (fr) 1997-05-01
EP0855912A1 (de) 1998-08-05

Similar Documents

Publication Publication Date Title
DE69617719D1 (de) Pharmazeutische zusammensetzung von stickstoffmonoxid
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
PL318172A1 (en) Novel analgesic pharmaceutic preparation
UA86344C2 (ru) Способ лечения сосудистых заболеваний
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
ATE326867T1 (de) Freie aminosäure enthaltende zusammensetzung
MY130157A (en) Method of use for inhibiting bone loss and lowering serum cholesterol
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
DK0706378T3 (da) Ny farmaceutisk formulering.
CA2241904A1 (en) Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
GR3007251T3 (de)
NO2012003I2 (no) 4-aminopyridin
DE69814394D1 (de) Verwendung von levobupivacain
IL108234A0 (en) Pharmaceutical composition containing galanthamine
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
NO994257D0 (no) Anvendelse av levobupivakain ved ansiktskirurgi
NO994259D0 (no) Anvendelse av levobupivakain ved pediatrisk kirurgi
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
Alon et al. Double-blind study of the reversal of midazolam-supplemented general anaesthesia with Ro 15–1788
DK492989A (da) Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
ATE243527T1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
ATE197402T1 (de) No-haltiges gasgemisch zur behandlung pulmonaler erkrankungen
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties